Patent ID: 7728005
Filing Date: 2010-06-01
Classification: A61P,C07C,C07D

Abstract:
1. An ether compound of formula (I), a pharmaceutically acceptable salt thereof, or a hydrate thereof: wherein Ar1 is an aryl group, Ar2 is a pyridazinyl group, pyrimidinyl group, pyrazinyl group, furyl group, thienyl group, pyrrolyl group, isoxazolyl group, oxazolyl group, isothiazolyl group, pyrazolyl group, imidazolyl group, benzofuranyl group, benzothienyl group, indolyl group, isoindolyl group, benzoxazolyl group, benzthiazolyl group, benzimidazolyl group, indazolyl group, benzisoxazolyl group, benzisothiazolyl group, quinolyl group, isoquinolyl group, cinnolinyl group, phthalazinyl group, quinazolinyl group or quinoxalinyl group, X is an oxygen atom or a sulfur atom, n is 0, R1-R3 are each independently a hydrogen atom or a C R4-R8 are each independently a hydrogen atom, a halogen atom, a C R9-R13 are each independently a hydrogen atom, a halogen atom, a C A is a hydrogen atom, a C wherein Ar3 is an aryl group, a heteroaryl group, or a nonaromatic heterocyclic group, Y is —O—, —CH Ra, Ra′, Rb and Rb′ are each independently a hydrogen atom or a C s is an integer of 1 or 2, t is an integer of 0-2, R14-R18 are each independently a hydrogen atom, a halogen atom, a C R19 is hydrogen atom or a C (1) when Ar2 is a bicyclic heteroaryl containing at least one nitrogen atom, then A is a group other than a hydrogen atom, and (2) the following compounds (X-1)-(X-7) are excluded